NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,086 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $216,433 | +6.8% | 2,033 | +1.3% | 0.02% | 0.0% |
| Q4 2023 | $202,647 | -13.0% | 2,007 | -12.3% | 0.02% | -21.4% |
| Q3 2023 | $233,056 | -0.4% | 2,288 | -1.3% | 0.03% | +3.7% |
| Q2 2023 | $233,909 | -7.1% | 2,318 | -15.3% | 0.03% | -12.9% |
| Q1 2023 | $251,712 | -2.5% | 2,736 | -3.9% | 0.03% | -8.8% |
| Q4 2022 | $258,189 | +14.2% | 2,846 | -4.1% | 0.03% | 0.0% |
| Q3 2022 | $226,000 | -11.7% | 2,967 | -1.9% | 0.03% | -10.5% |
| Q2 2022 | $256,000 | -8.9% | 3,023 | -5.6% | 0.04% | -2.6% |
| Q1 2022 | $281,000 | -0.4% | 3,203 | -0.7% | 0.04% | 0.0% |
| Q4 2021 | $282,000 | +15.1% | 3,226 | +7.8% | 0.04% | +2.6% |
| Q3 2021 | $245,000 | +2.1% | 2,992 | +13.8% | 0.04% | -2.6% |
| Q2 2021 | $240,000 | -4.4% | 2,630 | -10.4% | 0.04% | -4.9% |
| Q1 2021 | $251,000 | – | 2,936 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |